MoneyWorks4Me

Supriya Lifescience informs about press release

03 Oct 2022 Evaluate
Pursuant to the relevant provisions of the SEBI Listing Regulations, Supriya Lifescience has informed that it enclosing Press Release for Appointment of Rajeev Kumar Jain as Chief Executive Officer & Key Managerial Personnel with effective from October 3, 2022.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..